Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers

A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers
Condition:   HER2-amplified Biliary Tract Cancers
Interventions:   Drug: ZW25 (Zanidatamab);   Diagnostic Test: In situ hybridization (ISH)-based companion diagnostic assay;   Diagnostic Test: Immunohistochemistry (IHC)-based companion diagnostic assay
Sponsors:   Zymeworks Inc.;   BeiGene, Ltd.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 11, 2020 / by / in
Comments